RET and papillary carcinoma: For instance, increased miR-187 expression is reported in tumors with RET/PTC gene rearrangement, whereas that of miR-221 and miR-22 is observed in tumors positive for BRAF and RAS mutations as well as papillary carcinomas with unclear mutation.